Business
Result of General Meeting & Total Voting Rights
Result of General Meeting & Total Voting Rights.
About this update from Futura Medical Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 6135A\n Futura Medical PLC\n 02 June 2021\n \n \n \n \n NEITHER THIS ANNOUNCEMENT, NOR ANY COPY OF IT, MAY BE TAKEN OR TRANSMITTED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR TO ANY PERSONS IN ANY OF THOSE JURISDICTIONS OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.\n \n \n THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF FUTURA MEDICAL PLC. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.\n \n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE\n \n 7 OF MARKET ABUSE REGULATION (REGULATION 596/2014) (AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED) (\"UK MAR\").\n \n \n Unless otherwise indicated defined terms used in this announcement have the same meaning as those terms defined and used in the circular published in connection with the Fundraising, dated 17 May 2021.\n \n \n \n 2 June 2021\n \n \n Futura Medical plc\n \n \n (\"Futura\" or \"the Company\")\n \n \n Result of General Meeting & Total Voting Rights\n \n \n On 17 May 2021 Futura (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal Dermasys® drug delivery technology and currently focused on sexual health and pain, announced that it had conditionally raised £12 million in aggregate before fees and expenses through an oversubscribed Placing and Retail Offer with certain existing and new institutional and other investors at the Issue Price of 40 pence per share. \n \n \n The Company is pleased to announce that at the General Meeting held today, all Resolutions proposed were duly passed. The Fundraising remains conditional on, inter alia, Admission.\n \n \n The total number of votes received on each r...